{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:30:12Z","timestamp":1791405012776,"version":"4.3.3"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T00:00:00Z","timestamp":1625011200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005039","name":"Leids Universitair Medisch Centrum","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005039","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007051","name":"Uppsala Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000739","name":"University of Southampton","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000739","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ajog.2021.06.090","type":"journal-article","created":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T03:33:11Z","timestamp":1625196791000},"page":"624-633","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["Efficacy of combined oral contraceptives for depressive symptoms and overall symptomatology in premenstrual syndrome: pairwise and network meta-analysis of randomized trials"],"prefix":"10.1016","volume":"225","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9536-2148","authenticated-orcid":false,"given":"Anouk E.","family":"de Wit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ymkje Anna","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marrit K.","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celeste","family":"Scheper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ante","family":"Fokkema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharina A.H.","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik J.","family":"Giltay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Schoevers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2021.06.090_bib2","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S0140-6736(08)60527-9","article-title":"Premenstrual syndrome","volume":"371","author":"Yonkers","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2021.06.090_bib3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1017\/S0033291701004925","article-title":"Prevalence, incidence and stability of premenstrual dysphoric disorder in the community","volume":"32","author":"Wittchen","year":"2002","journal-title":"Psychol Med"},{"key":"10.1016\/j.ajog.2021.06.090_bib4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1089\/jwh.2008.0932","article-title":"Premenstrual syndrome prevalence and fluctuation over time: results from a French population-based survey","volume":"18","author":"Potter","year":"2009","journal-title":"J\u00a0Womens Health (Larchmt)"},{"key":"10.1016\/j.ajog.2021.06.090_bib5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2147\/OAJC.S183193","article-title":"Contraception counseling for women with premenstrual dysphoric disorder (PMDD): current perspectives","volume":"10","author":"Rapkin","year":"2019","journal-title":"Open Access J Contracept"},{"key":"10.1016\/j.ajog.2021.06.090_bib6","first-page":"e73","article-title":"Management of premenstrual syndrome: Green-top Guideline No. 48","volume":"124","year":"2017","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2021.06.090_bib7","first-page":"236","article-title":"Premenstrual syndrome and premenstrual dysphoric disorder","volume":"94","author":"Hofmeister","year":"2016","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.ajog.2021.06.090_bib9","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/01.AOG.0000175834.77215.2e","article-title":"Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder","volume":"106","author":"Yonkers","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.06.090_bib10","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.contraception.2005.08.021","article-title":"Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation","volume":"72","author":"Pearlstein","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2021.06.090_bib11","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/da.22673","article-title":"Treatment of premenstrual dysphoria with continuous versus intermittent dosing of oral contraceptives: results of a three-arm randomized controlled trial","volume":"34","author":"Eisenlohr-Moul","year":"2017","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.ajog.2021.06.090_bib12","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1089\/15246090152543148","article-title":"Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder","volume":"10","author":"Freeman","year":"2001","journal-title":"J\u00a0Womens Health Gend Based Med"},{"key":"10.1016\/j.ajog.2021.06.090_bib13","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.contraception.2011.09.010","article-title":"An overview of four studies of a continuous oral contraceptive (levonorgestrel 90 mcg\/ethinyl estradiol 20 mcg) on premenstrual dysphoric disorder and premenstrual syndrome","volume":"85","author":"Freeman","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2021.06.090_bib14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.contraception.2011.05.008","article-title":"Continuous oral levonorgestrel\/ethinyl estradiol for treating premenstrual dysphoric disorder","volume":"85","author":"Halbreich","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2021.06.090_bib15","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane handbook for systematic reviews of interventions version 6.2 (updated February 2021). Cochrane. 2021. Available from www.training.cochrane.org\/handbook. Accessed May 1, 2021."},{"key":"10.1016\/j.ajog.2021.06.090_bib16","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. (DSM-IV). 2006 Available at: https:\/\/ajp.psychiatryonline.org\/doi\/abs\/10.1176\/ajp.152.8.1228. Accessed May 1, 2021."},{"key":"10.1016\/j.ajog.2021.06.090_bib17","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1037\/1082-989X.7.1.105","article-title":"Combining effect size estimates in meta-analysis with\u00a0repeated measures and independent-groups designs","volume":"7","author":"Morris","year":"2002","journal-title":"Psychol Methods"},{"key":"10.1016\/j.ajog.2021.06.090_bib18","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2021.06.090_bib19","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jclinepi.2017.10.005","article-title":"Advances in the GRADE approach to rate the certainty in estimates from a network meta-analysis","volume":"93","author":"Brignardello-Petersen","year":"2018","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.ajog.2021.06.090_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003082","article-title":"CINeMA: an approach for assessing confidence in the results of a network meta-analysis","volume":"17","author":"Nikolakopoulou","year":"2020","journal-title":"PLoS Med"},{"key":"10.1016\/j.ajog.2021.06.090_bib21","doi-asserted-by":"crossref","first-page":"e1080","DOI":"10.1002\/cl2.1080","article-title":"CINeMA: software for semiautomated assessment of the confidence in the results of network meta-analysis","volume":"16","author":"Papakonstantinou","year":"2020","journal-title":"Campbell Syst Rev"},{"key":"10.1016\/j.ajog.2021.06.090_bib22","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.psyneuen.2016.11.033","article-title":"Combined oral contraceptive use is associated with both improvement and worsening of mood in the different phases of the treatment cycle\u2014a double-blind, placebo-controlled randomized trial","volume":"76","author":"Lundin","year":"2017","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.ajog.2021.06.090_bib23","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0306-4530(93)90024-F","article-title":"The relationship between mood and sexuality in women using an oral contraceptive as a treatment for premenstrual symptoms","volume":"18","author":"Graham","year":"1993","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.ajog.2021.06.090_bib24","doi-asserted-by":"crossref","first-page":"487143","DOI":"10.1155\/2013\/487143","article-title":"A\u00a0comparative efficacy of low-dose combined oral contraceptives containing desogestrel and drospirenone in premenstrual symptoms","volume":"2013","author":"Wichianpitaya","year":"2013","journal-title":"Obstet Gynecol Int"},{"key":"10.1016\/j.ajog.2021.06.090_bib25","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s43032-019-00080-x","article-title":"Does adding fluoxetine to combined oral contraceptives containing drospirenone improve the management of severe premenstrual syndrome? A 6-month randomized double-blind placebo-controlled three-arm trial","volume":"27","author":"Shehata","year":"2020","journal-title":"Reprod Sci"},{"key":"10.1016\/j.ajog.2021.06.090_bib26","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S0140-6736(15)61478-7","article-title":"Network meta-analysis: a norm for comparative effectiveness?","volume":"386","author":"Higgins","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2021.06.090_bib27","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ajog.2017.05.045","article-title":"Premenstrual disorders","volume":"218","author":"Yonkers","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.06.090_bib28","first-page":"CD006586","article-title":"Oral contraceptives containing drospirenone for premenstrual syndrome","author":"Lopez","year":"2012","journal-title":"Cochrane Database of Syst Rev"},{"key":"10.1016\/j.ajog.2021.06.090_bib29","first-page":"CD001396","article-title":"Selective serotonin reuptake inhibitors for premenstrual syndrome","author":"Marjoribanks","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2021.06.090_bib30","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000162296","article-title":"Psychological intervention for premenstrual syndrome: a meta-analysis of randomized controlled trials","volume":"78","author":"Busse","year":"2009","journal-title":"Psychother Psychosom"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937821007742?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937821007742?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:36:12Z","timestamp":1762079772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937821007742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0002937821007742"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2021.06.090","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of combined oral contraceptives for depressive symptoms and overall symptomatology in premenstrual syndrome: pairwise and network meta-analysis of randomized trials","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2021.06.090","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}